{
    "clinical_study": {
        "@rank": "13227", 
        "arm_group": [
            {
                "arm_group_label": "Bupivacaine", 
                "arm_group_type": "Active Comparator", 
                "description": "0.125% Bupivacaine HCL @ 4-5 ml/h"
            }, 
            {
                "arm_group_label": "Bupivacaine, Morphine", 
                "arm_group_type": "Active Comparator", 
                "description": "0.125% Bupivacaine HCL , Morphine sulphate 3 mg @ 3-5 ml/h"
            }, 
            {
                "arm_group_label": "Bupivacaine, Fentanyl", 
                "arm_group_type": "Active Comparator", 
                "description": "0.125% Bupivacaine, Fentanyl 100 mic @ 3-5 ml/h"
            }
        ], 
        "brief_summary": {
            "textblock": "we aim to compare the analgesic effect of 0.125% bupivacaine HCL, 0.125% bupivacaine HCL +\n      Morphine sulphate 3 mg, 0.125% bupivacaine HCL + Fentanyl 100 micro gram both at rest and\n      mobilization maneuvers."
        }, 
        "brief_title": "Postoperative Epidural Analgesia in Spine Fusion Surgery", 
        "completion_date": {
            "#text": "March 2013", 
            "@type": "Actual"
        }, 
        "condition": "Pain", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  patients undergoing spine fusion surgery.\n\n        Exclusion Criteria:\n\n          -  Drug addiction. Intraoperative dural tear. Uses of opioids drug for any reason in the\n             previous 48 hours. Mental dysfunction. Spinal fusion for any infectious or malignant\n             causes."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "60 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "April 20, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01838707", 
            "org_study_id": "1976"
        }, 
        "intervention": [
            {
                "arm_group_label": "Bupivacaine", 
                "intervention_name": "0.125% Bupivacaine HCL @ 4-5 ml/h", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Bupivacaine, Morphine", 
                "intervention_name": "0.125% Bupivacaine HCL , Morphine sulphate @ 3 mg 3-5 ml/h", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Bupivacaine, Fentanyl", 
                "intervention_name": "0.125% Bupivacaine, Fentanyl 100 mic @ 3-5 ml/h", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Bupivacaine", 
                "Fentanyl", 
                "Morphine"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "postoperative", 
            "spine surgery"
        ], 
        "lastchanged_date": "April 24, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Assiut", 
                    "country": "Egypt", 
                    "zip": "71111"
                }, 
                "name": "Assiut University Hospital"
            }
        }, 
        "location_countries": {
            "country": "Egypt"
        }, 
        "number_of_arms": "3", 
        "official_title": "Postoperative Epidural Analgesia in Spine Fusion Surgery", 
        "other_outcome": {
            "description": "3 serum samples for beta-endorphin will be taken 1st one preoperative base line , 2nd at VAS more than 3 at rest ,3rd when VAS less than 2 at rest", 
            "measure": "beta-endorphin", 
            "safety_issue": "Yes", 
            "time_frame": "1st postoperative day"
        }, 
        "overall_official": {
            "affiliation": "Assiut University", 
            "last_name": "Omnia A Abd El Raof, M.Sc.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Egypt: Institutional Review Board"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "March 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "\u2022\tPain will be assessed using the VAS ranging from \"0\" (no pain) to \"10\" (worst imaginable pain). Pain will be evaluated at rest, while coughing, and during mobilization. Maneuvers of particular clinical importance for postoperative mobilization (alone and with help) will be chosen: Turning in bed, standing in front of the bed and walking, and using the toilet without help. The time needed until the patient can first successfully perform these maneuvers will be documented.", 
            "measure": "Assessment of pain", 
            "safety_issue": "No", 
            "time_frame": "first 3 postoperative days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01838707"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Assiut University", 
            "investigator_full_name": "Omnia Askar", 
            "investigator_title": "assistant lecturer of anesthesia and ICU, Assiut University", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "verbal rating score will be used (4 = very satisfied, 3 = satisfied, 2 = neutral, 1 = dissatisfied, and 0 = very dissatisfied).", 
            "measure": "assessment of patients' satisfaction", 
            "safety_issue": "No", 
            "time_frame": "First 3 postoperative days"
        }, 
        "source": "Assiut University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Assiut University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2007", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Caregiver, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2013"
    }
}